Please ensure Javascript is enabled for purposes of website accessibility

Fresno Leaders Voice ‘Full Support’ for Pismo’s Restaurant Manager in ICE Custody

17 hours ago

Poll: Katie Porter Holds Early Edge in California Governor’s Race

19 hours ago

Just 38% of Americans Support Trump’s Use of Troops to Police DC, Reuters/Ipsos Poll Finds

20 hours ago

Families Leave Gaza City After Night of Bombardment, Israelis Protest

22 hours ago

California Farming Couple Seeks $300 Million for Aspen Estate

23 hours ago

Trump Administration Cannot Sue Maryland Federal Judges Over Immigration Order, Judge Rules

24 hours ago

California Republicans Sue to Block Congressional Redistricting Plan

2 days ago

Trump To Sign Executive Order Directing AG To Prosecute Flag Desecration

2 days ago

Fresno County DUI Crash Sends Car Into Embankment Near Highway 99

2 days ago
Pfizer: COVID-19 Shot 95% Effective, Seeking Clearance Soon
gvw_ap_news
By Associated Press
Published 5 years ago on
November 18, 2020

Share

Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe.

The announcement from Pfizer and its German partner BioNTech, just a week after they revealed the first promising preliminary results, comes as the team is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.

They also have begun “rolling submissions” for the vaccine with regulators in Europe, the U.K. and Canada and soon will add this new data.

Pfizer and BioNTech had initially estimated the vaccine was more than 90% effective after 94 infections had been counted in a study that included 44,000 people. With the new announcement, the company now has accumulated 170 infections in the study — and said only eight of them occurred in volunteers who got the actual vaccine rather than a dummy shot. One of those eight developed severe disease, the company said.

“This is an extraordinarily strong protection,” Dr. Ugur Sahin, BioNTech’s CEO and co-founder, told The Associated Press.

The companies have not yet released detailed data on its study, and results have not been analyzed by independent experts. Also still to be determined are important questions such as how long protection lasts and whether people might need boosters.

But all eyes are on the progress of potential vaccines as the grim infection rate jumps in the U.S. and abroad as winter weather forces people indoors, in the close quarters that fuels viral spread.

Pfizer and BioNTech said the vaccine was more than 94% effective in adults over age 65, though it is not clear exactly how that was determined with only eight infections in the vaccinated group to analyze and no breakdown provided of those people’s ages.

The Companies Have a Responsibility to Help Ensure Access for Lower Income Countries as Well

Sahin said there were enough older adults enrolled in the study and among the placebo recipients who became infected that he is confident “this vaccine appears to work in the higher-risk population.”

Earlier this week Moderna, Inc. announced that its experimental vaccine appears to be 94.5% effective after an interim analysis of its late-stage study.

Similar results from two vaccines both made with a brand-new technology — using a snippet of the genetic code of the coronavirus to train the body to recognize if the real virus comes along — likely will add to experts’ reassurance about the novel approach.

While initial supplies will be scarce and rationed, as the supply grows Sahin said the companies have a responsibility to help ensure access for lower income countries as well.

Pfizer and BioNTech also say now have the required data on the vaccine’s safety needed to seek emergency authorization from the Food and Drug Administration.

The companies didn’t disclose safety details but said no serious vaccine side effects have been reported, with the most common problem being fatigue after the second vaccine dose, affecting about 4% of participants.

The study has enrolled nearly 44,000 people in the U.S. and five other countries. The trial will continue to collect safety and effectiveness data on volunteers for two more years.

Pfizer and BioNTech said they expect to produce up to 50 million vaccine doses globally in 2020 and up to 1.3 billion doses in 2021.

U.S. officials have said they hope to have about 20 million vaccine doses each from Moderna and Pfizer available for distribution in late December. The first shots are expected to be offered to vulnerable groups like medical and nursing home workers, and people with serious health conditions.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Trump Administration Plans to Take Control of Washington Union Station

DON'T MISS

Israeli Tanks Close in on Gaza City, Trump to Chair Meeting

DON'T MISS

Trump Says Soros and His Son Should Be Charged With RICO

DON'T MISS

Wall Street Opens Muted in Countdown to Nvidia Earnings

DON'T MISS

Zohran Mamdani, Rapper Turned NYC Mayoral Frontrunner, Embraces Diverse Roots

DON'T MISS

California Searchers Pull Off High-Altitude Rescue of Missing Hiker

DON'T MISS

Judge Grants Fresno Temporary Win in Federal Grant DEI Dispute

DON'T MISS

Trump Administration Asks US Supreme Court to Halt Foreign Aid Payments

DON'T MISS

Hamas Challenges Israeli Account of Gaza Hospital Casualties

DON'T MISS

Fresno Unified Set to Hire Deputy Superintendent With Impressive Credentials

UP NEXT

Trump Says Soros and His Son Should Be Charged With RICO

UP NEXT

Zohran Mamdani, Rapper Turned NYC Mayoral Frontrunner, Embraces Diverse Roots

UP NEXT

Trump Administration Asks US Supreme Court to Halt Foreign Aid Payments

UP NEXT

Poll: Californians Overwhelmingly Reject Trump’s Immigration Policies

UP NEXT

Texas GOP Congressional Candidate Burns Quran With Flamethrower

UP NEXT

California High-Speed Rail Project Hit With New $175 Million Cut

UP NEXT

Poll: Katie Porter Holds Early Edge in California Governor’s Race

UP NEXT

Just 38% of Americans Support Trump’s Use of Troops to Police DC, Reuters/Ipsos Poll Finds

UP NEXT

US to Seek Death Penalty in Washington D.C. Homicide Cases, Trump Says

UP NEXT

Coarsegold Elementary Briefly Locked Down After Student Brings Starter Pistol

Wall Street Opens Muted in Countdown to Nvidia Earnings

16 minutes ago

Zohran Mamdani, Rapper Turned NYC Mayoral Frontrunner, Embraces Diverse Roots

18 minutes ago

California Searchers Pull Off High-Altitude Rescue of Missing Hiker

14 hours ago

Judge Grants Fresno Temporary Win in Federal Grant DEI Dispute

15 hours ago

Trump Administration Asks US Supreme Court to Halt Foreign Aid Payments

15 hours ago

Hamas Challenges Israeli Account of Gaza Hospital Casualties

15 hours ago

Fresno Unified Set to Hire Deputy Superintendent With Impressive Credentials

16 hours ago

Meta to Launch California Super PAC Backing Pro-AI Candidates

16 hours ago

Poll: Californians Overwhelmingly Reject Trump’s Immigration Policies

17 hours ago

Fresno Leaders Voice ‘Full Support’ for Pismo’s Restaurant Manager in ICE Custody

17 hours ago

Trump Administration Plans to Take Control of Washington Union Station

The U.S. Transportation Department said on Wednesday it planned to reclaim management of Washington Union Station, one of the country’...

1 minute ago

U.S. National Guard members patrol inside Union Station, after U.S. President Donald Trump deployed National Guard and ordered an increased presence of federal law enforcement to assist in crime prevention, in Washington, DC, U.S., August 21, 2025. (Reuters File)
1 minute ago

Trump Administration Plans to Take Control of Washington Union Station

An Israeli tank manouvres at the Israel-Gaza border, as seen from Israel, August 26, 2025. (Reuters File)
10 minutes ago

Israeli Tanks Close in on Gaza City, Trump to Chair Meeting

Billionaire investor George Soros speaks to the audience at the Schumpeter Award in Vienna, Austria June 21, 2019. (Reuters File)
14 minutes ago

Trump Says Soros and His Son Should Be Charged With RICO

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., July 1, 2025. (Reuters/Jeenah Moon)
16 minutes ago

Wall Street Opens Muted in Countdown to Nvidia Earnings

New York City mayoral candidate Zohran Mamdani speaks during a campaign event in the Bronx borough of New York City, U.S., August 14, 2025. (Reuters File)
18 minutes ago

Zohran Mamdani, Rapper Turned NYC Mayoral Frontrunner, Embraces Diverse Roots

On Tuesday, August 19, 2025, a hiker missing since August 16 was safely located and evacuated near Cottonwood Lakes during a multi-agency search and rescue operation. (Kern County SO)
14 hours ago

California Searchers Pull Off High-Altitude Rescue of Missing Hiker

Fresno City Gavel Lawsuit
15 hours ago

Judge Grants Fresno Temporary Win in Federal Grant DEI Dispute

People walk across the plaza of the U.S. Supreme Court building on the first day of the court's new term in Washington, U.S. October 3, 2022. (Reuters File)
15 hours ago

Trump Administration Asks US Supreme Court to Halt Foreign Aid Payments

Search

Help continue the work that gets you the news that matters most.

Send this to a friend